Le Lézard
Classified in: Tourism and vacations, Business, Covid-19 virus
Subject: CCA

Trip.com Group Reschedules the Announcement Date of its Fourth Quarter and Full Year 2019 Financial Results to March 18, 2020


SHANGHAI, Feb. 21, 2020 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM) ("Trip.com Group" or the "Company"), a leading provider of online travel and related services, including accommodation reservation, transportation ticketing, packaged tours and in-destination services, corporate travel management, and other travel-related services, today announced that it has rescheduled the announcement date for its financial results for the fourth quarter and full year 2019 to after the U.S. market closes on March 18, 2020.

Trip.com Group rescheduled the announcement date of its fourth quarter and full year 2019 financial results due to the evolving situation brought on by the novel coronavirus outbreak in China. The revised date would give the Company more time to observe business condition and provide visibility for the first quarter of 2020.

Trip.com Group's management will hold an earnings conference call at 8:00 PM on March 18, 2020, U.S. Eastern Time (8:00 AM on March 19, 2020, Beijing/Shanghai Time).

The conference call will be available on Webcast live and replay at: http://investors.trip.com. The call will be archived for twelve months at this website.

Listeners may access the call by dialling the following numbers:

 

US:

1-855-881-1339 or 1-914-202-3258

Hong Kong:

800-966-806

Mainland China:

4001-200-659

International:

+61-7-3145-4010

Passcode:

10003793

For pre-registration, please click

https://s1.c-conf.com/diamondpass/10003793-invite.html

A telephone replay of the call will be available after the conclusion of the conference call until March 26, 2020.  

The dial-in details for the replay:

International dial-in number:

+61-7-3107-6325

Passcode:

10003793

About Trip.com Group Ltd.

Trip.com Group Limited (Nasdaq: TCOM) is a leading one-stop travel service provider consisting of Trip.com, Ctrip, Skyscanner, and Qunar. Across its platforms, Trip.com Group enables local partners and travelers around the world to make informed and cost-effective bookings for travel products and services, through aggregation of comprehensive travel-related information and resources, and an advanced transaction platform consisting of mobile apps, Internet websites, and 24/7 customer service centers. Founded in 1999 and listed on Nasdaq in 2003, Trip.com Group has become one of the largest travel companies in the world in terms of gross merchandise value.

 

SOURCE Trip.com Group Limited


These press releases may also interest you

at 09:35
Two Clinical Trials Identify a Better Way to Target Appropriate Antibiotics for Patients Hospitalized With Pneumonia or Urinary Tract Infection
Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research...

at 09:25
United States Telehealth Weight Loss Market Report 2024-2028: Impacts of COVID and GLP-1 Meds Featuring Weight Watchers, Noom, Ro.co, , AmWell, Amazon, Teladoc, Form Health, Form Health Among Others - ResearchAndMarkets.com
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...

at 09:00
Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success
Amid growing concerns about a medical crisis as a result of acute conflict between the government...

at 08:45
Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against QuidelOrtho Corporation
Wolf Haldenstein Adler Freeman & Herz LLP  ("Wolf  Haldenstein") announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern  District of New York on behalf of investors who purchased...

at 08:00
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, is happy to announce that its wholly owned generic pharmaceutical subsidiary, Nora...

at 07:00
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...

More news about Covid-19 virus...


News published on and distributed by: